Peptide Atlas · Mineral
Potassium phosphate (injectable)
In a randomized study in critically ill patients with hypophosphatemia, 30 or 45 mmol of intravenous potassium phosphate corrected phosphate by the end of the infusion in 98%, whether given over 2 or 4 hours (moderate) or 3 or 6 hours (severe), with no adverse events.
- emerging
- provisional
- PubChem 24450
- 1 citation
- 0 discussions
- 0 followers
- dipotassium hydrogen phosphate (K2HPO4)
- monopotassium phosphate (KH2PO4)
- potassium phosphate for injection
What the evidence says
six tiers, never blendedemerging — human data exists, and it is thin or contested
every claim resolves to its source
All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.
Negative findings
failure is informationNobody has filed a failure yet. Failures are information; this list is waiting for an honest one.